Cardioprotective interventions for cancer patients receiving anthracyclines

EC van Dalen, HN Caron… - … of systematic reviews, 2011 - cochranelibrary.com
Background Anthracyclines are among the most effective chemotherapeutic agents in the
treatment of numerous malignancies. Unfortunately, their use is limited by a dose …

Protecting against anthracycline‐induced myocardial damage: a review of the most promising strategies

KA Wouters, LCM Kremer, TL Miller… - British journal of …, 2005 - Wiley Online Library
Over the last 40 years, great progress has been made in treating childhood and adult
cancers. However, this progress has come at an unforeseen cost, in the form of emerging …

Recommendations for cardiomyopathy surveillance for survivors of childhood cancer: a report from the International Late Effects of Childhood Cancer Guideline …

SH Armenian, MM Hudson, RL Mulder… - The Lancet …, 2015 - thelancet.com
Survivors of childhood cancer treated with anthracycline chemotherapy or chest radiation
are at an increased risk of developing congestive heart failure. In this population, congestive …

Medical assessment of adverse health outcomes in long-term survivors of childhood cancer

MM Geenen, MC Cardous-Ubbink, LCM Kremer… - Jama, 2007 - jamanetwork.com
ContextImproved survival of children with cancer has been accompanied by multiple
treatment-related complications. However, most studies in survivors of childhood cancer …

Antibiotic prophylaxis for bacterial infections in afebrile neutropenic patients following chemotherapy

A Gafter‐Gvili, A Fraser, M Paul, L Vidal… - Cochrane database …, 2012 - cochranelibrary.com
Background Bacterial infections are a major cause of morbidity and mortality in patients who
are neutropenic following chemotherapy for malignancy. Trials have shown the efficacy of …

Different anthracycline derivates for reducing cardiotoxicity in cancer patients

EC van Dalen, EMC Michiels… - Cochrane Database …, 2006 - cochranelibrary.com
Background The use of anthracycline chemotherapy is limited by the occurrence of
cardiotoxicity. In an effort to prevent this cardiotoxicity, different anthracycline derivates have …

A worldwide collaboration to harmonize guidelines for the long‐term follow‐up of childhood and young adult cancer survivors: a report from the International Late …

LCM Kremer, RL Mulder, KC Oeffinger… - Pediatric blood & …, 2013 - Wiley Online Library
Childhood and young adult cancer survivors should receive optimum care to reduce the
consequences of late effects and improve quality of life. We can facilitate achieving this goal …

Clinical heart failure in a cohort of children treated with anthracyclines: a long-term follow-up study

EC van Dalen, HJH van der Pal, WEM Kok… - European journal of …, 2006 - Elsevier
The cumulative incidence of anthracycline-induced clinical heart failure (A-CHF) in a large
cohort of 830 children treated with a mean cumulative anthracycline dose of 288mg/m2 …

Long-term risk of subsequent malignant neoplasms after treatment of childhood cancer in the DCOG LATER study cohort: role of chemotherapy

JC Teepen, FE van Leeuwen, WJ Tissing… - Journal of Clinical …, 2017 - research.rug.nl
Purpose: Childhood cancer survivors (CCSs) are at increased risk for subsequent malignant
neoplasms (SMNs). We evaluated the long-term risk of SMNs in a well-characterized cohort …

Recommendations for breast cancer surveillance for female survivors of childhood, adolescent, and young adult cancer given chest radiation: a report from the …

RL Mulder, LCM Kremer, MM Hudson, S Bhatia… - The lancet …, 2013 - thelancet.com
Female survivors of childhood, adolescent, and young adult (CAYA) cancer who were given
radiation to fields that include breast tissue (ie, chest radiation) have an increased risk of …